Michael Traeubel

Title: Michael Traeubel: Innovator in Endoparasiticidal Compositions

Introduction

Michael Traeubel is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of veterinary medicine, particularly in the development of compositions aimed at controlling endoparasites. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving animal health.

Latest Patents

One of Michael Traeubel's key patents is titled "Endoparasiticidal compositions for topical application." This invention relates to transdermally applicable compositions that comprise cyclic depsipeptides and/or praziquantel. The patent outlines the preparation and use of these compositions for effectively controlling endoparasites in animals. Michael Traeubel holds 1 patent in this area, reflecting his focused research and development efforts.

Career Highlights

Throughout his career, Michael Traeubel has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bayer Animal Health GmbH and Bayer Intellectual Property GmbH. His roles in these organizations have allowed him to contribute to significant advancements in animal health products.

Collaborations

Michael Traeubel has collaborated with esteemed colleagues, including Venkata-Rangarao Kanikanti and Thomas Bach. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Michael Traeubel's work in developing endoparasiticidal compositions highlights his commitment to advancing veterinary medicine. His contributions through patents and collaborations with industry leaders underscore the importance of innovation in improving animal health.